[1] |
Fenwick E, Rees G, Pesudovs K,et al.Social and emotional impact of diabetic retinopathy:a review[J]. Clin Exp Ophthalmol, 2012, 40(1):27-38.DOI: 10.1111/j.1442-9071.2011.02599.x.
|
[2] |
Bloomgarden ZT.American diabetes association annual meeting,1999:more on cardiovascular disease[J]. Diabetes Care, 2000, 23(6):845-852.DOI: 10.2337/diacare.23.6.845.
|
[3] |
Valmadrid CT, Klein R, Moss SE,et al.The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus[J]. Arch Intern Med, 2000, 160(8):1093-1100.DOI: 10.1001/archinte.160.8.1093.
|
[4] |
Srinath Reddy K, Shah B, Varghese C,et al.Responding to the threat of chronic diseases in India[J]. Lancet, 2005, 366(9498):1744-1749.DOI: 10.1016/S0140-6736(05)67343-6.
|
[5] |
Yusuf S, Reddy S, Ounpuu S,et al.Global burden of cardiovascular diseases:part I:general considerations,the epidemiologic transition,risk factors,and impact of urbanization[J]. Circulation, 2001, 104(22):2746-2753.DOI: 10.1161/hc4601.099487.
|
[6] |
Grundy SM, Benjamin IJ, Burke GL,et al.Diabetes and cardiovascular disease:a statement for healthcare professionals from the American Heart Association[J]. Circulation, 1999, 100(10):1134-1146.DOI: 10.1161/01.cir.100.10.1134.
|
[7] |
Selvin E, Marinopoulos S, Berkenblit G,et al.Meta-analysis:glycosylated hemoglobin and cardiovascular disease in diabetes mellitus[J]. Ann Intern Med, 2004, 141(6):421-431.DOI: 10.7326/0003-4819-141-6-200409210-00007.
|
[8] |
Halil M, Yavuz B, Yavuz BB, et al. Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score[J]. J Cardiovasc Med (Hagerstown), 2008, 9(7):683-687.DOI: 10.2459/JCM.0b013e3282f394a5.
|
[9] |
Ruggiero C, Cherubini A, Ble A,et al.Uric acid and inflammatory markers[J]. Eur Heart J, 2006, 27(10):1174-1181.DOI: 10.1093/eurheartj/ehi879.
|
[10] |
Wilson PW, D′Agostino RB, Agostino RB, et al. Prediction of coronary heart disease using risk factor categories[J]. Circulation, 1998, 97(18):1837-1847.DOI: 10.1161/01.cir.97.18.1837.
|
[11] |
苗志敏.高尿酸血症//葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:790-794.
|
[12] |
Bonakdaran S,Hami M,Shakeri MT.Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus[J].Iran J Kidney Dis,2011,5(1):21-24.
|
[13] |
Dehghan A, van Hoek M, Sijbrands EJ,et al.High serum uric acid as a novel risk factor for type 2 diabetes[J]. Diabetes Care, 2008, 31(2):361-362.DOI: 10.2337/dc07-1276.
|
[14] |
Yu S, Chen Y, Hou X,et al.Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes:a systematic review and meta-analysis[J]. Mol Neurobiol, 2016, 53(2):1045-1051.DOI: 10.1007/s12035-014-9075-0.
|
[15] |
Du L, Ma J, Zhang X.Higher serum uric acid may contribute to cerebral infarction in patients with type 2 diabetes mellitus:a meta-analysis[J]. J Mol Neurosci, 2017, 61(1):25-31.DOI: 10.1007/s12031-016-0848-y.
|
[16] |
Liese AD, Hense HW, Löwel H,et al.Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort.World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases[J]. Epidemiology, 1999, 10(4):391-397.DOI: 10.1097/00001648-199907000-00006.
|
[17] |
Høieggen A, Alderman MH, Kjeldsen SE,et al.The impact of serum uric acid on cardiovascular outcomes in the LIFE study[J]. Kidney Int, 2004, 65(3):1041-1049.DOI: 10.1111/j.1523-1755.2004.00484.x.
|
[18] |
Kim SY, Guevara JP, Kim KM,et al.Hyperuricemia and coronary heart disease:a systematic review and meta-analysis[J]. Arthritis Care Res (Hoboken), 2010, 62(2):170-180.DOI: 10.1002/acr.20065.
|
[19] |
Kanjilal S, Rao VS, Mukherjee M,et al.Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians[J]. Vasc Health Risk Manag, 2008, 4(1):199-211.DOI: 10.2147/vhrm.2008.04.01.199.
|
[20] |
Myerson M, Coady S, Taylor H,et al.Declining severity of myocardial infarction from 1987 to 2002:the Atherosclerosis Risk in Communities (ARIC) Study[J]. Circulation, 2009, 119(4):503-514.DOI: 10.1161/CIRCULATIONAHA.107.693879.
|
[21] |
Chamnan P, Simmons RK, Sharp SJ, et al. Cardiovascular risk assessment scores for people with diabetes:a systematic review[J]. Diabetologia, 2009, 52(10):2001-2014.DOI: 10.1007/s00125-009-1454-0.
|
[22] |
Kushiyama A, Okubo H, Sakoda H,et al.Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development[J]. Arterioscler Thromb Vasc Biol, 2012, 32(2):291-298.DOI: 10.1161/ATVBAHA.111.234559.
|
[23] |
Bickel C, Rupprecht HJ, Blankenberg S,et al.Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J]. Am J Cardiol, 2002, 89(1):12-17.DOI: 10.1016/s0002-9149(01)02155-5.
|
[24] |
D′Agostino RB Sr, Grundy S, Sullivan LM,et al.Validation of the Framingham coronary heart disease prediction scores:results of a multiple ethnic groups investigation[J]. JAMA, 2001, 286(2):180-187.DOI: 10.1001/jama.286.2.180.
|
[25] |
Barzi F, Patel A, Gu D,et al.Cardiovascular risk prediction tools for populations in Asia[J]. J Epidemiol Community Health, 2007, 61(2):115-121.DOI: 10.1136/jech.2005.044842.
|
[26] |
Katsiki N, Karagiannis A, Athyros VG,et al.Hyperuricaemia:more than just a cause of gout?[J]. J Cardiovascular Med (Hagerstown), 2013, 14(6):397-402.DOI: 10.2459/JCM.0b013e3283595adc.
|
[27] |
Nagao A, Seki M, Kobayashi H.Inhibition of xanthine oxidase by flavonoids[J]. Biosci Biotechnol Biochem, 1999, 63(10):1787-1790.DOI: 10.1271/bbb.63.1787.
|